Clinical trial
A Prospective Phase II Randomized Clinical Study of Radiotherapy or Observation of Liver Metastases for Small Cell Lung Cancer.
NCT05150145 is registered in ClinicalTrials.gov with Guizhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Phase II Randomized Clinical Study of Radiotherapy or Observation of Liver Metastases for Small Cell Lung Cancer.
- Lead sponsor
- Guizhou Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 30, 2021
- Completion date
- March 1, 2026
- Enrollment
- 66 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
radiotherapy; complications